Breast Cancer
What's New
Last Posted: Mar 24, 2023
- Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
Giovanna Garufi et al. Therapeutic advances in medical oncology 2023 1517588359221138657 - The implementation of NILS: A web-based artificial neural network decision support tool for noninvasive lymph node staging in breast cancer.
Looket Dihge et al. Frontiers in oncology 2023 131102254 - Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer.
Yongcheng Chen et al. Gland surgery 2023 12(2) 197-207 - Cascade Genetic Risk Education and Testing in Families With Hereditary Cancer Syndromes: A Pilot Study.
Steven J Katz et al. JCO oncology practice 2023 OP2200677 - Concordance between 21-gene recurrence score assay and clinicopathological predictive models in early-breast cancer patients cared for at a cancer center in Colombia.
Mauricio Luján et al. Gaceta medica de Mexico 2023 159(1) 3-9 - Are population level familial risks and germline genetics meeting each other?
Kari Hemminki et al. Hereditary cancer in clinical practice 2023 21(1) 3 - Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
Lauren G Santos et al. JAMA network open 2023 6(3) e231723 - Association of Breast Cancer Family History With Breast Density Over Time in Korean Women.
Thi Xuan Mai Tran et al. JAMA network open 2023 6(3) e232420 - BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil.
Patricia Mazzonetto et al. Breast cancer research and treatment 2023 - Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review.
Gillian Parker et al. PloS one 2023 18(3) e0280582 - Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs.
David C Boyd et al. Cancers 2023 15(5) - Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.
Tufia C Haddad et al. JAMA oncology 2023 - Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study.
Antonio Llombart-Cussac et al. Cancers 2023 15(5) - Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.
Guan-Qiao Li et al. Frontiers in endocrinology 2023 141103949 - Artificial intelligence-based model for lymph node metastases detection on whole slide images in bladder cancer: a retrospective, multicentre, diagnostic study.
Shaoxu Wu et al. The Lancet. Oncology 2023 - A novel deep learning model for breast lesion classification using ultrasound Images: A multicenter data evaluation.
Nasim Sirjani et al. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) 2023 107102560 - Applications of different machine learning approaches in prediction of breast cancer diagnosis delay.
Samira Dehdar et al. Frontiers in oncology 2023 131103369 - Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer.
Nicholas A Borja et al. Frontiers in oncology 2023 131068110 - Breast Cancer Screening Utilization and Outcomes in Women With Neurofibromatosis Type 1.
Kevin Yan et al. Clinical breast cancer 2023 - Construction of a prognostic risk assessment model for HER2 + breast cancer based on autophagy-related genes.
Fan Wang et al. Breast cancer (Tokyo, Japan) 2023
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 27, 2023
- Content source: